How to Use International Models for Canadian Access

The challenge in Canada is rarely a lack of evidence: It’s that different decision-makers require different answers from the same evidence package. Most clinical and economic evidence is developed from a global perspective, while Canadian access decisions are made within a uniquely fragmented public and private payer environment. Take back to your team valuable insights you can use to help you: 

• Understand how the evolution of international policies and priorities will impact evidence requirements for Canada 
• Navigate the misalignments between global evidence strategies and local decision-making needs  
• Take advantage of as emerging opportunities to leverage new forms of evidence to better support market access strategies in Canada 

Translate global market access successes into actionable, local initiatives that expedite patient access and improve your portfolio viability in the Canadian market.